← Back to Screener
Natural Alternatives International Inc. (NAII)
Price$2.69
Favorite Metrics
Price vs S&P 500 (26W)-3.61%
Price vs S&P 500 (4W)-3.15%
Market Capitalization$16.29M
All Metrics
P/CF (Annual)2.75x
Book Value / Share (Quarterly)$10.85
P/TBV (Annual)2.41x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-8.77%
Cash Flow / Share (Quarterly)$-0.85
Price vs S&P 500 (YTD)-27.50%
Gross Margin (TTM)9.06%
Net Profit Margin (TTM)-9.06%
EPS (TTM)$-2.04
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-2.04
Revenue Growth (5Y)1.78%
EPS (Annual)$-2.28
ROI (Annual)-17.13%
Gross Margin (Annual)7.15%
Net Profit Margin (5Y Avg)-0.57%
Cash / Share (Quarterly)$0.61
Revenue Growth QoQ (YoY)2.10%
ROA (Last FY)-8.93%
Revenue Growth TTM (YoY)10.92%
EBITD / Share (TTM)$-0.17
ROE (5Y Avg)-0.04%
Operating Margin (TTM)-4.15%
Cash Flow / Share (Annual)$0.38
P/B Ratio0.24x
P/B Ratio (Quarterly)0.33x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.20x
Net Interest Coverage (TTM)-4.15x
ROA (TTM)-7.94%
EV / EBITDA (TTM)15.54x
EPS Incl Extra (Annual)$-2.28
Current Ratio (Annual)2.06x
Quick Ratio (Quarterly)0.66x
3-Month Avg Trading Volume0.02M
52-Week Price Return-8.81%
EV / Free Cash Flow (Annual)11.70x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$3.79
P/S Ratio (Annual)0.13x
Asset Turnover (Annual)0.85x
52-Week High$4.96
Operating Margin (5Y Avg)0.91%
EPS Excl Extra (Annual)$-2.28
CapEx CAGR (5Y)-4.46%
Tangible BV CAGR (5Y)5.40%
26-Week Price Return0.37%
Quick Ratio (Annual)0.96x
13-Week Price Return-42.89%
Total Debt / Equity (Annual)0.16x
Current Ratio (Quarterly)1.87x
Enterprise Value$27.118
Revenue / Share Growth (5Y)4.24%
Asset Turnover (TTM)0.88x
Book Value / Share Growth (5Y)1.07%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)4.91x
Pretax Margin (Annual)-8.27%
Cash / Share (Annual)$1.99
3-Month Return Std Dev78.51%
Gross Margin (5Y Avg)11.97%
Net Income / Employee (TTM)$-0
ROE (Last FY)-19.84%
Net Interest Coverage (Annual)-2.41x
EPS Basic Excl Extra (Annual)$-2.28
P/FCF (TTM)2.30x
Receivables Turnover (TTM)7.80x
Total Debt / Equity (Quarterly)0.22x
EPS Incl Extra (TTM)$-2.04
Receivables Turnover (Annual)8.24x
ROI (TTM)-14.90%
P/S Ratio (TTM)0.12x
Pretax Margin (5Y Avg)0.11%
Revenue / Share (Annual)$21.84
Tangible BV / Share (Annual)$4.42
Price vs S&P 500 (52W)-38.64%
Year-to-Date Return-24.86%
5-Day Price Return-1.82%
EPS Normalized (Annual)$-2.28
ROA (5Y Avg)0.96%
Net Profit Margin (Annual)-10.45%
Month-to-Date Return2.28%
Cash Flow / Share (TTM)$0.89
EBITD / Share (Annual)$-0.69
Operating Margin (Annual)-6.67%
LT Debt / Equity (Annual)0.13x
ROI (5Y Avg)0.44%
LT Debt / Equity (Quarterly)0.13x
EPS Basic Excl Extra (TTM)$-2.04
P/TBV (Quarterly)2.37x
P/B Ratio (Annual)0.30x
Inventory Turnover (TTM)4.35x
Pretax Margin (TTM)-5.91%
Book Value / Share (Annual)$11.08
Price vs S&P 500 (13W)-43.58%
Beta0.41x
P/FCF (Annual)7.03x
Revenue / Share (TTM)$22.50
ROE (TTM)-17.43%
52-Week Low$2.33
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
NAIINatural Alternatives International Inc. | 0.12x | 10.92% | 9.06% | — | $2.69 |
CRONCronos Group Inc. Common Share | 7.06x | 24.63% | 42.81% | -49.98% | $2.68 |
TLRYTilray Brands, Inc. Common Stock | 0.92x | 3.82% | 27.68% | — | $6.79 |
CGCCanopy Growth Corporation Common Shares | 2.42x | 0.59% | 26.56% | — | $1.15 |
NAGENiagen Bioscience, Inc. Common Stock | 2.93x | 29.95% | 64.28% | — | $4.73 |
USNAUSANA Health Sciences Inc | 0.38x | 5.88% | 78.29% | -37.04% | $19.06 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.51 |
MDWDMediWound Ltd. | 13.10x | -16.14% | 19.19% | — | $17.10 |
ACBAurora Cannabis Inc. Common Shares | 0.78x | 16.54% | 1.35% | — | $3.61 |
FTLFFitLife Brands, Inc. Common Stock | 1.34x | 1.34% | 37.58% | -20.04% | $9.25 |
BTMDBiote Corp. Class A Common Stock | 0.41x | -2.52% | 71.46% | -26.84% | $2.10 |
About
Natural Alternatives International is a nutritional supplement and healthcare product manufacturer serving U.S. and international markets through contract manufacturing and licensing. Its Private-Label Contract Manufacturing segment, the primary revenue driver, manufactures supplements and healthcare products for third-party distributors. The company also generates royalty income through patent and trademark licensing agreements.